Inflammasomes and interferons constitute two critical arms of innate immunity. Most facultative bacterial 11 pathogens that inhabit the host cell cytosol avoid activating inflammasomes and are often resistant to 12 killing by type I interferon (IFN-I). We report that the human pathogen Rickettsia parkeri, an obligate 13 intracellular pathogen that resides in the cytosol, is sensitive to IFN-I. The mechanism of IFN-I-14 dependent restriction requires the transcription factor IRF5, which upregulates anti-rickettsial factors 15 including guanylate-binding proteins and iNOS. However, R. parkeri curtails cGAS-dependent IFN-I 16 production by causing caspase-11-dependent pyroptosis. In vivo, inflammasome activation antagonizes 17 IFN-I production, enhancing R. parkeri abundance in the spleen. Mice lacking either IFN-I or IFN-g 18 signaling are resistant to infection, but mice lacking both rapidly succumb, revealing that both interferons 19 are required to control R. parkeri. This study illuminates how an obligate cytosolic pathogen exploits the 20 intrinsic trade-off between cell death and cytokine production to escape killing by innate immunity. 21 22 Highlights 23 • Rickettsia killed by GBPs activates caspase-11 and GSDMD, promoting pyroptosis 24 • Rickettsia exploits pyroptosis to avoid cGAS-dependent type I interferon 25 • IRF5, GBPs, and iNOS contribute to controlling R. parkeri infection 26 • Ifnar -/-Ifngr -/mice succumb to infection, uncovering a mouse model to study R. parkeri 27 28 Keywords 29 Inflammasome; type I interferon; IFN-g; Rickettsia parkeri; IRF5; guanylate-binding proteins; GBP2; 30 GBP5; caspase-11; cGAS 31 32 33 34 35 36 42 cytosol (Brubaker et al., 2015; McNab et al., 2015; Wallet et al., 2016). However, less well understood 43 are the innate immune responses to obligate intracellular bacterial pathogens. Spotted fever group 44 (SFG) Rickettsia spp. are tick-borne pathogens that cause spotted fever diseases worldwide (Walker 45 and Ismail, 2008). As obligate intracellular bacteria that replicate exclusively in the host cell cytosol, 46 SFG Rickettsia spp. must continually interface with host innate immune sensors. Therefore, they 47 presumably have evolved sophisticated mechanisms to avoid or even exploit innate immune responses.
Introduction

37
The innate immune response to microbial pathogens depends on upregulation of antimicrobial 38 factors, secretion of cytokines, and activation of host cell death pathways (Jorgensen and Miao, 2015;  39 Meunier and Broz, 2016; Mitchell and Isberg, 2017; Randow et al., 2013) . Innate immune responses 40 have been characterized during infection with facultative intracellular bacterial pathogens such as 41 Listeria monocytogenes and virulent Francisella species, as well as viruses, which inhabit the host cell Gbp5 and three other Gbp genes. Bacterial growth was then measured upon IFN-I treatment. In IFN-I-225 treated Gbp chr3-/macrophages, bacterial growth was increased 3-to-5-fold compared with that in WT 226 IFN-I-treated macrophages (Figure 4A) . No change in bacterial growth was observed in the other 227 mutant macrophages upon IFN-I treatment (Figure S2B) . When pyroptosis was assessed by measuring 228 LDH-release, Gbp chr3 -deficient macrophages showed dramatically reduced cell death upon infection,
229
whereas the other mutant cells did not (Figure 4B) . Gbp chr3-/macrophages did not exhibit increased 230 IFN-I production (Figure 4C) , consistent with the notion that the GBPs are required for release of 231 bacterial LPS as well as DNA. These data suggested that GBPs contribute to both IFN-I-dependent and 232 IFN-I-independent killing of R. parkeri. Next, to assess the role for nitric oxide during R. parkeri infection,
233
we treated WT-and Gbp chr3 -infected cells with IFN-I and the specific iNOS inhibitor L-NIL and monitored 234 bacterial growth. Upon iNOS inhibition, bacterial growth was increased in both WT and Gbp chr3-/cells The GBPs have been observed to localize to the surface of intracellular pathogens at steady-250 state conditions and upon the addition of interferons (Liu et al., 2018; Mitchell and Isberg, 2017;  251 Yamamoto et al., 2012) . To determine if the GBPs localized to the surface of R. parkeri, we performed 252 immunofluorescence microscopy using a GBP2-specific antibody. GBP2 localized to the surface of ~1% 253 of bacteria in untreated WT cells at 3 hpi, and ~5% of total bacteria in IFN-I treated cells (Figure 4G , 254 H). No colocalization was observed in infected Gbp chr3-/macrophages, demonstrating that the antibody 255 is specific for the GBPs (Figure S3 ). Together, these data demonstrate that the GBPs localize to R. 256 parkeri and restrict bacterial growth at steady-state conditions, which is enhanced by IFN-I.
258
In spleens, the inflammasome antagonizes the anti-rickettsial effects of IFN-I
259
Our data from macrophages suggested a model for R. parkeri intracellular survival whereby reduced bacterial burdens when compared to WT (as in macrophages); nevertheless, these data reveal 277 that the mechanisms of R. parkeri growth in spleens is similar to macrophages in vitro, where bacterial 278 activation of the inflammasome limits the antimicrobial effects of cGAS-induced IFN-I.
279
In macrophages, we also observed a role for IFN-g in restricting R. parkeri growth; however, the 280 role for IFN-g and its relationship to the inflammasome during Rickettsia infection in vivo is unknown.
281
We therefore next assessed if IFN-g restricted R. parkeri growth in the spleens of infected mice.
282
Neutralization of IFN-g using an anti-IFN-g antibody increased bacterial burdens in Casp1 -/-Casp11 -/-283 mice 2.5-fold when compared to untreated Casp1 -/-Casp11 -/mice, suggesting that IFN-g restricts were removed, we next tested whether these cytokines were protective at the whole animal level. We weight and their body temperature decreased, which then recovered to pre-infection levels. We also 319 performed these experiments using AG129 mice, which are similarly mutated for Ifngr and Ifnar, but are 320 in a different genetic background. These mice were also highly susceptible to infection with 10 7 bacteria, 321 with 100% fatality by 6 dpi (Figure 6D) . Together, these data demonstrate that both IFN-I and IFN-g 322 potently control R. parkeri growth in animals. The discovery of the sensitivity of this mouse genotype 323 reveals it as robust animal model for further investigations into pathogenesis of the SFG Rickettsia.
325
Discussion inflammasome, the innate immune response to obligate intracellular bacteria has remained largely 329 unexplored. We report the unexpected discovery that the innate immune response to the obligate 330 intracellular human pathogen R. parkeri is distinctive among other cytosolic pathogens, as the bacteria 331 are sensitive to IFN-I-mediated killing, but avoid stimulating a robust IFN-I response by exploiting the 332 inherent trade-off between inflammasome activation and IFN-I production.
333
We observed that R. parkeri were restricted by IFN-I in macrophages and in mice. Furthermore,
334
IFN-I much more potently restricted R. parkeri in macrophages than was previously seen for other , 2010) . We propose that inflammasome 356 activation is a trade-off that allows for growth of a pathogen that is sensitive to IFN-I.
357
Downstream of IFN-I production, we observed that the transcription factor IRF5 is critical for 
363
These data also reveal an unappreciated role for the GPBs in rickettsial killing. We observed that iNOS 364 and GBPs acted additively and non-redundantly, and only partially account for the killing effects of IFN-365 I. We suspect that additional IRF5-regulated genes contribute to controlling R. parkeri infection, and 366 identifying these factors will be critical for understanding how interferons control infection by obligate 367 pathogens.
368
Consistent with our observations in macrophages in vitro, we found that the inflammasome 369 antagonizes IFN-I production in vivo. However, we observed tissue-specific differences in the spleen 
373
Our observations expand on these previous findings, by revealing that an inherent trade-off of 374 pyroptosis is that it limits protective IFN-I in the spleen. However, in the liver, IFN-I enhances infection 375 due to its effects of antagonizing IFN-g. These observations are also in agreement with a previous study 376 demonstrating that cytokine production is the more important facet of inflammasome activation in the that IFN-I and IFN-g act differently in the spleen and liver, we speculate that interferons may pressure 383 pathogens to evolve organ-specific tropisms to accommodate their intracellular lifestyle.
384
In keeping with our observations that IFN-I and IFN-g restrict R. parkeri growth in macrophages 385 in vitro, we observed that Ifnar -/-Ifngr -/mice rapidly succumbed to infection. These findings demonstrate 386 that both types of interferon play a critical role in protecting against R. parkeri infection. Our observations 387 are also of strong practical importance, as this mouse exhibits a pathology that makes it a useful animal 388 model for future studies examining the bacterial determinants that contribute to SFG Rickettsia 389 pathogenesis and for evaluating the impacts of infection at the organ, tissue and cellular levels in vivo.
390
Future studies will aim to characterize facets of infection including dissemination, vascular damage, as 391 well as the innate immune response.
392
Our data suggest that obligate cytosolic pathogens such as R. parkeri may occupy an 
